As broad-spectrum antibiotics, fluoroquinolones (FQs) have gained increasing use and have become popular in clinical application thanks to their high bacteriologic and clinical cure rates and good pharmacokinetic profile. 1 Prulifloxacin (PUFX, Scheme 1), 6-fluoro-1-methyl-7-(4-[5-methyl-2-oxo-1,3-dioxolen-4-yl]-methyl-1-piprazinyl)-4-oxo-4H-(1,3)thiaceto(3,2-α)quinolone-3-carboxylic acid, is a new oral fluoroquinolone antibiotics. It is active against both gram-positive and gram-negative bacteria and several anaerobic and atypical bacteria associated with chronic bronchitis and urinary infections.
Introduction
As broad-spectrum antibiotics, fluoroquinolones (FQs) have gained increasing use and have become popular in clinical application thanks to their high bacteriologic and clinical cure rates and good pharmacokinetic profile. 1 Prulifloxacin (PUFX, Scheme 1), 6-fluoro-1-methyl-7-(4-[5-methyl-2-oxo-1,3-dioxolen-4-yl]-methyl-1-piprazinyl)-4-oxo-4H-(1,3)thiaceto(3,2-α)quinolone-3-carboxylic acid, is a new oral fluoroquinolone antibiotics. It is active against both gram-positive and gram-negative bacteria and several anaerobic and atypical bacteria associated with chronic bronchitis and urinary infections. 2 After PUFX is administrated, it is immediately and quantitatively transformed to the active metabolite ulifloxacin (UFX, Scheme 1) which actually has antibacterial activity. Prulifloxacin is not detectable in the systemic circulation. 3 That is to say, PUFX is the prodrug of UFX. The oxodioxolenylmethyl group in the 7-piperazine ring helps PUFX to have an advantage over UFX on oral absorption. 3 Thus, the main form existing in biological fluids, such as serum and urine, is UFX. It is thus necessary to develop rapid, selective and sensitive analytical methods for the determination and pharmacokinetic study of UFX.
Analytical literature about the determination of UFX is seldom seen. There are a few papers that describe HPLC methods. [4] [5] [6] The HPLC methods allow the separation and generally require expensive equipment and complicated procedures. The main advantages of fluorometry are simplicity and rapidity. Luminescence sensitization of lanthanide ions (especially Tb(III) and Eu(III)) allows their application as the luminescence probes. Lanthanide-sensitized luminescence provides a selective and sensitive approach that shows a large stokes shift, narrow emission bands and a long luminescence lifetime. The carboxylate and the keto oxygen atoms of FQs provide the chelated sites for Tb(III) or Eu(III) ion to form Ln(III)-FQ complex. When Tb(III)-FQ complex is excited, it gives rise to the characteristic luminescence of Tb(III) ion with maximum emission at 545 nm via intramolecular energy transfer. This terbium-sensitized method has been used in the determination of FQs. [7] [8] [9] [10] [11] In recent years, the light scattering technique has been increasingly applied to analytical chemistry, the most common method used is resonance light scattering (RLS). In studying RLS, the strong scattering of light at double the wavelength of the incident light (λem = 2λex) is found, which is named as "second-order scattering (SOS)". 12 As it may interfere with fluorometric measurements, SOS is always minimized and if possible eliminated as a harmful phenomenon in the fluorometric determinations. 13 Since Liu et al. first studied SOS as an analytical technique and applied it in the determination of metal ions in 1995, 14, 15 however, it has been used as a new analytical technique with sensitive application prospects. 16, 17 We have reported some flow-injection lanthanide-sensitized chemiluminescence (CL) [18] [19] [20] and electrochemiluminescence (ECL) 21, 22 methods for the determination of other fluoroquinolones.
The methods often attained higher sensitivities. However, different fluoroquinolones attained different sensitivity, and sometimes the sensitivity also depends on the apparatus. The apparatus of CL and ECL are not so allpervading as spectrofluorometers. For ECL especially, the electrode needs pretreatment before each experiment, and it has not been combined with flow-injection. In comparison with them, the SOS method is carried out on a common spectrofluorometer, and the manipulation is very simple.
The excitation spectrum of Tb(III)-UFX has two main peaks: the larger one locates at about 273 nm, while the other locates at about 340 nm. When we choose 273 nm as the incident light to excite Tb(III)-UFX, the most intensive emission locates at 545 nm, which includes the fluorescence intensity of Tb(III) ion and the SOS intensity. Herein, this paper reports determination of ulifloxacin by terbium-sensitized fluorescence with a SOS method.
Experimental

Reagents
All reagents used were of analytical grade. Double-distilled water was used throughout the experiment. UFX (Beijing Synthesis Sky Chemical Technology Co. Ltd., China) standard stock solution (5.0 × 10 -4 mol L -1 ) was prepared by dissolving 17.4 mg UFX in 1 mol L -1 NaOH solution and diluting with water to 100 mL. A standard stock solution of the Tb(III) ion (0.01 mol L -1 ) was prepared by dissolving 934.5 mg Tb4O7 in 15.0 mL of HCl (11.6 mol L -1 ) at 100˚C, evaporating the solution until almost dry, then diluting it to 500 mL with water. More dilute solutions were freshly prepared by diluting the stock solution.
Apparatus
The fluorescence and SOS measurements were carried out on an M 850 spectrofluorometer (Hitachi, Japan). Each pH measurement was made with a 420Aplus pH meter (Orion Research, Inc., Beverly, USA).
Procedure
One milliliter of certain concentration of UFX solutions, 0.5 mL 1.0 × 10 -2 mol L -1 of Tb(III) ion, and 5 mL acetic acid-sodium acetate (HAc-NaAc) buffer solution (0.1 mol L -1 , pH 5.0) were added to a 10-mL test tube. The mixture was diluted to 10 mL with water and mixed thoroughly. Then the total intensity of fluorescence and SOS was recorded at room temperature. The excitation and emission wavelengths were 273 nm (slits, 8 nm) and 545 nm (slits, 12 nm), respectively. The relative intensity ΔI in the text means the difference between the intensity of the sample solution and that of the blank solution.
Serum and urine samples treatment
Blank serum and urine samples were kindly provided by several volunteers. A 1.0-mL volume of 1.0 × 10 -4 , 1.5 × 10 -4 , 2.0 × 10 -4 mol L -1 UFX were added to 1 mL serum respectively, followed by adding 3.0 mL trichloroacetic acid (CCl3COOH) (10%) for deproteinization, after which centrifugation for 15 min at 4000 r min -1 was performed. Take 1.0 mL of the clear liquid in 50 mL calibrated flask, and dilute to the volume with water. The urine samples need no further pretreatments, and were diluted with water only. A 1.0-mL volume of 4.0 × 10 -5 , 6.0 × 10 -5 , 8.0 × 10 -5 mol L -1 UFX were each added to 1 mL blank urine samples, and then they were diluted with water to 100 mL. Add 1.0 mL the diluted serum or urine samples to 10-mL test tubes. The other reagents were added following the general procedure. The standard additions method was used for the recovery study of UFX by adding different known amounts of UFX to the samples, which were then treated in the same way as the calibration samples. The blank values were determined by treating drug-free serum or urine in the same way.
Results and Discussion
Optimization of experimental variables
Optimization of experimental conditions for the determination of UFX was carried out. The pH of the system has a significant influence on the relative intensity. The effect of pH was studied in the range of 3.1 -6.9. Results showed that the relative intensity enhances with increasing of pH when pH is below 4.0, then the intensity almost remains constant over the pH range 4.0 -5.5. At higher pH, the intensity decreases. So pH 5.0 was chosen for the further study. At pH 5.0, several buffer solutions including HAc-NaAc, KHP (potassium hydrogen phthalate)-NaOH and Cit (citric acid)-Na3Cit (sodium citrate) buffer solutions were tested; concentrations of all of them were 0.1 mol L -1 . Finally, HAc-NaAc was selected as the pH controller because it could enhance the relative intensity at 545 nm, while the other buffer solutions quenched the emission.
The concentration of Tb(III) ion is another factor which affects the relative intensity. The intensity increased with the increase of Tb(III) ion concentration, but when the concentration was higher than 5.0 × 10 -4 mol L -1 , the increase became inconspicuous. Thus, 5.0 × 10 -4 mol L -1 Tb(III) was chosen for the subsequent work.
Spectra characteristics
The excitation and emission spectra of UFX and Tb(III)-UFX are shown in Fig. 1 . Both UFX and Tb(III)-UFX have two main excitation peaks: one locates at 273 nm, the other locates at about 340 nm. In the earlier reports about Tb(III) sensitized fluorescence, in order to avoid direct excitation of Tb(III), 23 the disturbance of the scattered excitation light and the inner filtering effect, 24 273 nm was not used as the incident wavelength, although it would bring higher sensitivity. As shown in Fig. 1 , the native fluorescence emission of UFX shows broad peak centers at about 430 nm. When Tb(III) ion was introduced, the wide emission band of UFX decreased evidently, while the unique emission bands of Tb(III) ion (peaks at 489, 545, 584 and 621 nm) appeared. As we know, emission 1374 ANALYTICAL SCIENCES DECEMBER 2007, VOL. 23 of Tb(III) ion in aqueous solution is very weak, but the emission of Tb(III) in Tb(III)-UFX is strong. This phenomenon indicates that the complex Tb(III) with UFX has formed and that intramolecular energy transfer occurred. Since second-order scattering (SOS) has become a new analytical technique, we have tried to use 273 nm as the excitation wavelength. We found that the total intensity at 545 nm also was a linear relationship to the concentration of UFX, and the sensitivity of determination was enhanced. By compared with 340 nm, 273 nm as the excitation wavelength will lead to stronger emission intensity originally, but the SOS intensity can not be neglected.
Interference studies
For the sake of assessing the applied possibility of the method, the influences of some metal ions in human body, some common excipients used in pharmaceutical preparations and some organic compounds on the relative fluorescence intensity were investigated for the determination of 1.0 × 10 -6 mol L -1 UFX. The experiments were performed by comparing with the intensities obtained without and with foreign substances added. A foreign species is considered to interfere if it produces an error greater than ±5% in the determination of UFX. The results are listed in Table 1 . It can be seen that most substances give no interference, but some do. Since the content of proteins in human serum is very high, in order to eliminate their interference, a deproteinization procedure was needed before serum samples determination.
Analytical characteristics
Under optimum conditions described above, the linear range for the determination of UFX is 2.0 × 10 The detection limit calculated from the standard deviation of the blank (the reagent blank without UFX, n = 11) (3σ) is 3.9 × 10 -9 mol L -1 . The relative standard deviation (RSD) was 2.4% for 11 determinations of 5.0 × 10 -7 mol L -1 UFX.
Analytical applications
It was reported that the maximum concentration of UFX in the serum is between 1 μg mL -1 (2.8 × 10 -6 mol L -1 ) and 1.6 μg mL -1 (4.6 × 10 -6 mol L -1 ) after a single oral administration of 300, 450 and 600 mg PUFX. The concentration of UFX in urine is very high after dosing, in contrast and can reach more than 60 μg mL -1 (1.7 × 10 -4 mol L -1 ). 3 Following the previously described procedure, the method was applied to the determination of UFX in spiked human serum and urine. Data are summarized in Table 2 . The recoveries of UFX in serum and urine were 90.5 -96.5% and 104.2 -107.2%, respectively.
The luminescence property of Tb(III)-FQ by comparing UFX with norfloxacin and ofloxacin
The phenomenon of intramolecular energy transfer from the ligand to the Ln(III) is commonly seen among lanthanide complexes, especially Tb(III) and Eu(III) complexes. As for the complex of Tb(III)-UFX, when it is excited by the UV light, the strongly characteristic luminescence of Tb(III) appears through the intramolecular energy transfer process.
Fluoroquinolones (FQs) are a family of antibiotics which have similar structures. All of the FQs possess the carboxylate and the keto oxygen, which make them able to form complexes with Tb(III). And all of them have two excitation peaks: one locates at about 273 nm, the other locates around 320 nm. But when the complexes Tb(III)-FQs are excited at 273 nm, the total emission intensities at 545 nm are quite different. Because the SOS intensity is not strong, the fluorescence intensity, which is dependent upon the energy transfer efficiency, plays a crucial role in the total intensity. Although FQs have the same nucleus, structural variations, especially the N1 substituents, can affect their abilities to chelate with Tb(III) ion and the energy transfer efficiencies. 23 The introduction of substituents with different donor properties results in the electron density redistribution over pyridine ring and affects the charge of the oxygen atoms. 25 Take norfloxacin (NFLX), ofloxacin (OFLX) (Scheme 2) and UFX as examples. For ofloxacin, the benzoxazine group appears as an efficient electron-attracting system acting as a quencher of the fluorescence process. 23 For NFLX and UFX, the ethyl group and the thioceto group on the N1 position act as 1375 ANALYTICAL SCIENCES DECEMBER 2007, VOL. 23 Recovery ± RSD, % (n = 5)
electron-donors; this may induce the increasing in the charge density of the oxygen atoms which coordinated with Tb(III). But compared with ethyl group, the thioceto group is larger, which may confuse the coordination. The fluorescence and SOS spectra were obtained and are shown in Fig. 2 . From the point of view of the Förster theory, in order to promote energy transfer efficiently, there should be some overlaps between the fluorescence spectrum of the donor and the absorption spectrum of the acceptor. 26 The emission spectrum of FQs and the absorption spectrum of Tb(III) ion are shown in Fig. 3 . It can be observed that the overlaps between the emission spectra of FQs and the absorption spectrum of Tb(III) decrease as the following sequence: NFLX, UFX and OFLX. This is consistent with the luminescence intensity observed. ANALYTICAL SCIENCES DECEMBER 2007, VOL. 23 
